

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 6.81011804 |
| 2 | negative regulation of glucose import (GO:0046325) | 6.56888126 |
| 3 | negative regulation of glucose transport (GO:0010829) | 6.33683711 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.82457705 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 5.30393042 |
| 6 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.83641680 |
| 7 | cellular response to ethanol (GO:0071361) | 4.66717924 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64726981 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.64726981 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38965721 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.28577574 |
| 12 | mannose metabolic process (GO:0006013) | 4.23034240 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.22758078 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.20370489 |
| 15 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.14011872 |
| 16 | natural killer cell activation involved in immune response (GO:0002323) | 4.10234372 |
| 17 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.01379983 |
| 18 | natural killer cell differentiation (GO:0001779) | 3.94535256 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.94369219 |
| 20 | ER overload response (GO:0006983) | 3.82643555 |
| 21 | regulation of B cell differentiation (GO:0045577) | 3.80417243 |
| 22 | regulation of B cell proliferation (GO:0030888) | 3.76610117 |
| 23 | histone H3-K4 trimethylation (GO:0080182) | 3.73694635 |
| 24 | B cell proliferation (GO:0042100) | 3.70033320 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68165967 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.68165967 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68165967 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.68165967 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68165967 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68165967 |
| 31 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67258771 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.64723209 |
| 33 | cellular extravasation (GO:0045123) | 3.63454372 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.62071682 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.60869580 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.60869580 |
| 37 | response to type I interferon (GO:0034340) | 3.57389834 |
| 38 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 3.57158034 |
| 39 | embryonic process involved in female pregnancy (GO:0060136) | 3.55955196 |
| 40 | T cell homeostasis (GO:0043029) | 3.55120547 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54826516 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51740038 |
| 43 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.48890147 |
| 44 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.48890147 |
| 45 | interferon-gamma production (GO:0032609) | 3.48561329 |
| 46 | positive regulation of protein homooligomerization (GO:0032464) | 3.48062913 |
| 47 | T cell migration (GO:0072678) | 3.47038036 |
| 48 | respiratory burst (GO:0045730) | 3.44187360 |
| 49 | B cell homeostasis (GO:0001782) | 3.36834120 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36757430 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34060754 |
| 52 | GDP-mannose metabolic process (GO:0019673) | 3.30967350 |
| 53 | positive T cell selection (GO:0043368) | 3.27949762 |
| 54 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.26912705 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.23478591 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.22855511 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18717391 |
| 58 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18178094 |
| 59 | leukocyte aggregation (GO:0070486) | 3.18165817 |
| 60 | positive regulation of immunoglobulin production (GO:0002639) | 3.14231827 |
| 61 | negative thymic T cell selection (GO:0045060) | 3.13595333 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12202855 |
| 63 | natural killer cell activation (GO:0030101) | 3.12072649 |
| 64 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 3.07322797 |
| 65 | positive regulation of defense response to virus by host (GO:0002230) | 3.05583550 |
| 66 | histone-serine phosphorylation (GO:0035404) | 3.05489116 |
| 67 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04804428 |
| 68 | negative T cell selection (GO:0043383) | 3.04779725 |
| 69 | neutrophil activation involved in immune response (GO:0002283) | 3.04769941 |
| 70 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.01690479 |
| 71 | positive thymic T cell selection (GO:0045059) | 3.01428387 |
| 72 | negative regulation of interleukin-6 production (GO:0032715) | 3.01215674 |
| 73 | regulation of B cell activation (GO:0050864) | 2.99720976 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99619097 |
| 75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98578833 |
| 76 | regulation of fibroblast apoptotic process (GO:2000269) | 2.98528306 |
| 77 | necroptotic process (GO:0070266) | 2.96695649 |
| 78 | cellular response to glucose starvation (GO:0042149) | 2.96183284 |
| 79 | lymphocyte homeostasis (GO:0002260) | 2.95821436 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 2.95773002 |
| 81 | regulation of energy homeostasis (GO:2000505) | 2.95467872 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94510786 |
| 83 | protein maturation by protein folding (GO:0022417) | 2.94277209 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92670988 |
| 85 | positive regulation of B cell proliferation (GO:0030890) | 2.91222906 |
| 86 | mast cell activation (GO:0045576) | 2.89335800 |
| 87 | response to peptidoglycan (GO:0032494) | 2.87718459 |
| 88 | hepatocyte apoptotic process (GO:0097284) | 2.87139346 |
| 89 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.83993480 |
| 90 | B cell mediated immunity (GO:0019724) | 2.82305154 |
| 91 | regulation of necroptotic process (GO:0060544) | 2.81899845 |
| 92 | T cell selection (GO:0045058) | 2.77479324 |
| 93 | T cell activation involved in immune response (GO:0002286) | 2.77088089 |
| 94 | tolerance induction (GO:0002507) | 2.76971604 |
| 95 | myeloid cell activation involved in immune response (GO:0002275) | 2.76071278 |
| 96 | signal peptide processing (GO:0006465) | 2.75940922 |
| 97 | positive regulation of B cell activation (GO:0050871) | 2.74620710 |
| 98 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.73702675 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73273805 |
| 100 | regulation of T cell migration (GO:2000404) | 2.73185469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.51919514 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.63537521 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.71459541 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.23441218 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.57424328 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.49215321 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38688772 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28039472 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.20562618 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.00546586 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87091819 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86900655 |
| 13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.81416910 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73987087 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65947604 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.64216110 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.62070123 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.52801887 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40135403 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39229997 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38241249 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.34198889 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32386968 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.31561016 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31196966 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17218101 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 2.11335646 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06271442 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.03777591 |
| 30 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.97538611 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89968389 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82137276 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81841169 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81697685 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80845697 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75860461 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75493618 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61147578 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58904874 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58726658 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55537967 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54006070 |
| 43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.53057418 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50093606 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48424909 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.45603396 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44424235 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42586491 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41880400 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41474370 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38828854 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35562979 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34058607 |
| 54 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33964919 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31969763 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29211021 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29072683 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28040413 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23521101 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22873368 |
| 61 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21897783 |
| 62 | GATA3_26560356_Chip-Seq_TH1_Human | 1.19765644 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19022473 |
| 64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18620110 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18121520 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16885795 |
| 67 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.14709211 |
| 68 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.14709211 |
| 69 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.14709211 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13924874 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12209794 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11706503 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11553695 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09337662 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08756513 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03328946 |
| 77 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97596467 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95018120 |
| 79 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93628606 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88094310 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87691357 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87614451 |
| 83 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87551588 |
| 84 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87115584 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84802419 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84418873 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82952652 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82771021 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82661339 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82282147 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81681689 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80735775 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79764489 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79657189 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79419505 |
| 96 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77522934 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77066905 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75878395 |
| 99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73901213 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.73037068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.20473224 |
| 2 | MP0005671_abnormal_response_to | 4.17900290 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.73068887 |
| 4 | MP0001800_abnormal_humoral_immune | 3.57985641 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.10930654 |
| 6 | MP0003436_decreased_susceptibility_to | 3.10076648 |
| 7 | MP0000685_abnormal_immune_system | 3.08474413 |
| 8 | MP0000015_abnormal_ear_pigmentation | 3.03829844 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.89655919 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.83523331 |
| 11 | MP0003724_increased_susceptibility_to | 2.82979869 |
| 12 | MP0002723_abnormal_immune_serum | 2.80624075 |
| 13 | MP0005387_immune_system_phenotype | 2.72821194 |
| 14 | MP0001790_abnormal_immune_system | 2.72821194 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.59665221 |
| 16 | MP0001819_abnormal_immune_cell | 2.57151026 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.56035906 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.48430322 |
| 19 | MP0002419_abnormal_innate_immunity | 2.45417314 |
| 20 | MP0009785_altered_susceptibility_to | 2.42570781 |
| 21 | MP0005025_abnormal_response_to | 2.37410531 |
| 22 | MP0002398_abnormal_bone_marrow | 2.30681700 |
| 23 | MP0002254_reproductive_system_inflammat | 2.26878309 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.24595633 |
| 25 | MP0000716_abnormal_immune_system | 2.11145406 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.94705122 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.84086888 |
| 28 | MP0002722_abnormal_immune_system | 1.82044018 |
| 29 | MP0008260_abnormal_autophagy | 1.81216099 |
| 30 | MP0004510_myositis | 1.79649294 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.79294135 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.74724681 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.73421344 |
| 34 | MP0002429_abnormal_blood_cell | 1.72026212 |
| 35 | MP0006082_CNS_inflammation | 1.71895008 |
| 36 | MP0002405_respiratory_system_inflammati | 1.69575435 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.67577053 |
| 38 | MP0001873_stomach_inflammation | 1.65250986 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.65150218 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.64653865 |
| 41 | MP0005310_abnormal_salivary_gland | 1.59153914 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.58251664 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.57519565 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.57304522 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.53532861 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.53532861 |
| 47 | MP0009764_decreased_sensitivity_to | 1.45663661 |
| 48 | MP0006054_spinal_hemorrhage | 1.44627344 |
| 49 | MP0002132_abnormal_respiratory_system | 1.41246114 |
| 50 | MP0004947_skin_inflammation | 1.38464985 |
| 51 | MP0003045_fibrosis | 1.36904945 |
| 52 | MP0009278_abnormal_bone_marrow | 1.35267932 |
| 53 | MP0004130_abnormal_muscle_cell | 1.24606139 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.24366309 |
| 55 | MP0008469_abnormal_protein_level | 1.19727092 |
| 56 | MP0004381_abnormal_hair_follicle | 1.17732535 |
| 57 | MP0003866_abnormal_defecation | 1.11347308 |
| 58 | MP0004036_abnormal_muscle_relaxation | 1.10811769 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.05453286 |
| 60 | MP0000569_abnormal_digit_pigmentation | 0.99847187 |
| 61 | MP0003075_altered_response_to | 0.99275998 |
| 62 | MP0003950_abnormal_plasma_membrane | 0.98584234 |
| 63 | MP0002396_abnormal_hematopoietic_system | 0.96933548 |
| 64 | MP0001853_heart_inflammation | 0.95415481 |
| 65 | MP0002693_abnormal_pancreas_physiology | 0.92955649 |
| 66 | MP0001919_abnormal_reproductive_system | 0.91614040 |
| 67 | MP0001663_abnormal_digestive_system | 0.90666561 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.88574640 |
| 69 | MP0001851_eye_inflammation | 0.86922281 |
| 70 | MP0002095_abnormal_skin_pigmentation | 0.86032844 |
| 71 | MP0001529_abnormal_vocalization | 0.85535497 |
| 72 | MP0008004_abnormal_stomach_pH | 0.84237801 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.79237662 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.78679923 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.75977002 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.74946439 |
| 77 | MP0003795_abnormal_bone_structure | 0.71728201 |
| 78 | MP0000490_abnormal_crypts_of | 0.71122025 |
| 79 | MP0003828_pulmonary_edema | 0.70837293 |
| 80 | MP0002933_joint_inflammation | 0.70453213 |
| 81 | MP0002019_abnormal_tumor_incidence | 0.69142564 |
| 82 | MP0004145_abnormal_muscle_electrophysio | 0.67303965 |
| 83 | MP0005451_abnormal_body_composition | 0.66480416 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.62673645 |
| 85 | MP0001727_abnormal_embryo_implantation | 0.62457115 |
| 86 | MP0000249_abnormal_blood_vessel | 0.61982418 |
| 87 | MP0001915_intracranial_hemorrhage | 0.60025660 |
| 88 | MP0003091_abnormal_cell_migration | 0.59978702 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.59892580 |
| 90 | MP0000858_altered_metastatic_potential | 0.59545537 |
| 91 | MP0000604_amyloidosis | 0.58617198 |
| 92 | MP0000371_diluted_coat_color | 0.58430084 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.57966675 |
| 94 | MP0008874_decreased_physiological_sensi | 0.57022377 |
| 95 | MP0002006_tumorigenesis | 0.56174333 |
| 96 | MP0009763_increased_sensitivity_to | 0.55556546 |
| 97 | MP0003448_altered_tumor_morphology | 0.55538133 |
| 98 | MP0004142_abnormal_muscle_tone | 0.53900931 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.52684425 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.52587522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nonimmune hydrops fetalis (HP:0001790) | 6.27794557 |
| 2 | Stomatitis (HP:0010280) | 4.50140626 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.34407055 |
| 4 | Thrombocytosis (HP:0001894) | 4.25663884 |
| 5 | Gastrointestinal infarctions (HP:0005244) | 4.20131510 |
| 6 | Hypoplasia of the pons (HP:0012110) | 3.91637299 |
| 7 | IgA deficiency (HP:0002720) | 3.88698426 |
| 8 | Abnormality of the pons (HP:0007361) | 3.82935171 |
| 9 | Chronic sinusitis (HP:0011109) | 3.81682380 |
| 10 | Global brain atrophy (HP:0002283) | 3.77302791 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.62538387 |
| 12 | Acute hepatic failure (HP:0006554) | 3.60626107 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.59309530 |
| 14 | Optic neuritis (HP:0100653) | 3.59309530 |
| 15 | Meningitis (HP:0001287) | 3.54820898 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.48204559 |
| 17 | Nuclear cataract (HP:0100018) | 3.46100656 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.40965200 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.34733662 |
| 20 | Gingival bleeding (HP:0000225) | 3.33961127 |
| 21 | Papilloma (HP:0012740) | 3.32428035 |
| 22 | Verrucae (HP:0200043) | 3.32428035 |
| 23 | Recurrent viral infections (HP:0004429) | 3.25039983 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.24481480 |
| 25 | Orchitis (HP:0100796) | 3.23269951 |
| 26 | Glucose intolerance (HP:0000833) | 3.21348963 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.15751309 |
| 28 | IgG deficiency (HP:0004315) | 3.15444337 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.14916896 |
| 30 | Myositis (HP:0100614) | 3.14418392 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.13148252 |
| 32 | Lymphopenia (HP:0001888) | 3.07419385 |
| 33 | Vasculitis (HP:0002633) | 3.02305863 |
| 34 | Recurrent pneumonia (HP:0006532) | 2.98136344 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94726551 |
| 36 | Albinism (HP:0001022) | 2.94161793 |
| 37 | Spastic paraparesis (HP:0002313) | 2.93168643 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.91412945 |
| 39 | Chest pain (HP:0100749) | 2.90060192 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81589123 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81589123 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81589123 |
| 43 | Cellulitis (HP:0100658) | 2.81388087 |
| 44 | Cutaneous melanoma (HP:0012056) | 2.78072682 |
| 45 | Testicular atrophy (HP:0000029) | 2.76964483 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76841108 |
| 47 | Obstructive lung disease (HP:0006536) | 2.74936337 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74936337 |
| 49 | Abnormality of homocysteine metabolism (HP:0010919) | 2.72803454 |
| 50 | Homocystinuria (HP:0002156) | 2.72803454 |
| 51 | Megaloblastic anemia (HP:0001889) | 2.70249552 |
| 52 | Peritonitis (HP:0002586) | 2.69244890 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.67829227 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.67400106 |
| 55 | T lymphocytopenia (HP:0005403) | 2.67289935 |
| 56 | Spontaneous abortion (HP:0005268) | 2.66057556 |
| 57 | Epistaxis (HP:0000421) | 2.64821091 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.64024449 |
| 59 | Arterial thrombosis (HP:0004420) | 2.61014718 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.60050474 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55275088 |
| 62 | Abnormality of T cells (HP:0002843) | 2.50789962 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.48833269 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.48792117 |
| 65 | Osteomyelitis (HP:0002754) | 2.45049824 |
| 66 | Restrictive lung disease (HP:0002091) | 2.42061311 |
| 67 | Hematochezia (HP:0002573) | 2.41370295 |
| 68 | Encephalitis (HP:0002383) | 2.41353525 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.41267186 |
| 70 | Purpura (HP:0000979) | 2.40031626 |
| 71 | Prolonged partial thromboplastin time (HP:0003645) | 2.39710299 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.36595897 |
| 73 | Chronic otitis media (HP:0000389) | 2.36132344 |
| 74 | Abnormality of the pericardium (HP:0001697) | 2.34494681 |
| 75 | Increased IgM level (HP:0003496) | 2.34297982 |
| 76 | Petechiae (HP:0000967) | 2.33552177 |
| 77 | Abnormal protein glycosylation (HP:0012346) | 2.32307127 |
| 78 | Abnormal glycosylation (HP:0012345) | 2.32307127 |
| 79 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32307127 |
| 80 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32307127 |
| 81 | Hypoalbuminemia (HP:0003073) | 2.31476499 |
| 82 | Abnormal albumin level (HP:0012116) | 2.31476499 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29848285 |
| 84 | Increased serum ferritin (HP:0003281) | 2.28781390 |
| 85 | Polyneuropathy (HP:0001271) | 2.27331052 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25457339 |
| 87 | Fatigue (HP:0012378) | 2.24601068 |
| 88 | Keratitis (HP:0000491) | 2.24545306 |
| 89 | Sepsis (HP:0100806) | 2.23805883 |
| 90 | Abnormal glucose tolerance (HP:0001952) | 2.23275837 |
| 91 | Myocardial infarction (HP:0001658) | 2.21281375 |
| 92 | Hemoptysis (HP:0002105) | 2.20787760 |
| 93 | Severe visual impairment (HP:0001141) | 2.18731990 |
| 94 | Leukocytosis (HP:0001974) | 2.17604261 |
| 95 | Vacuolated lymphocytes (HP:0001922) | 2.15204019 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.14018058 |
| 97 | Recurrent skin infections (HP:0001581) | 2.11930603 |
| 98 | Recurrent sinusitis (HP:0011108) | 2.10958880 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10722979 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10722979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMKK2 | 5.97305475 |
| 2 | PKN2 | 5.14119621 |
| 3 | BRSK2 | 4.73165296 |
| 4 | IRAK4 | 3.78135978 |
| 5 | CAMKK1 | 3.30274810 |
| 6 | FLT3 | 3.26347611 |
| 7 | IRAK2 | 2.88061098 |
| 8 | TYK2 | 2.70084397 |
| 9 | MAP4K1 | 2.59837229 |
| 10 | IRAK1 | 2.41761249 |
| 11 | RIPK4 | 2.34569884 |
| 12 | PASK | 2.22213752 |
| 13 | TXK | 2.13454182 |
| 14 | MAP3K14 | 2.08349360 |
| 15 | IKBKE | 2.03095601 |
| 16 | BRSK1 | 1.97460126 |
| 17 | JAK3 | 1.88782626 |
| 18 | BTK | 1.85335332 |
| 19 | SIK3 | 1.75867903 |
| 20 | PIK3CG | 1.69733623 |
| 21 | AKT3 | 1.69248265 |
| 22 | SYK | 1.62572585 |
| 23 | TEC | 1.59905504 |
| 24 | TBK1 | 1.56100614 |
| 25 | BLK | 1.52943402 |
| 26 | HCK | 1.51173475 |
| 27 | ITK | 1.49103761 |
| 28 | PRPF4B | 1.31577471 |
| 29 | EIF2AK3 | 1.20899628 |
| 30 | TLK1 | 1.20517019 |
| 31 | IKBKB | 1.15128678 |
| 32 | MAP3K9 | 1.04337876 |
| 33 | CSK | 1.04190722 |
| 34 | ERN1 | 1.03415014 |
| 35 | JAK1 | 0.93196002 |
| 36 | STK10 | 0.92331644 |
| 37 | MAP3K10 | 0.92092850 |
| 38 | JAK2 | 0.89960382 |
| 39 | SIK2 | 0.86196757 |
| 40 | MAPK11 | 0.86011176 |
| 41 | TNK2 | 0.81933298 |
| 42 | LYN | 0.81887704 |
| 43 | MAP3K13 | 0.81080011 |
| 44 | TAOK2 | 0.80626930 |
| 45 | MATK | 0.79203954 |
| 46 | PRKCQ | 0.77849088 |
| 47 | FES | 0.77843385 |
| 48 | FGR | 0.76744923 |
| 49 | CSF1R | 0.74773668 |
| 50 | MAP3K11 | 0.74713411 |
| 51 | MAP2K3 | 0.74241127 |
| 52 | ZAP70 | 0.73185986 |
| 53 | STK24 | 0.73137662 |
| 54 | MARK3 | 0.67821467 |
| 55 | KIT | 0.66006894 |
| 56 | GRK6 | 0.62275639 |
| 57 | BMPR2 | 0.62076097 |
| 58 | LCK | 0.61403359 |
| 59 | TYRO3 | 0.60500603 |
| 60 | TAOK3 | 0.58216324 |
| 61 | TAOK1 | 0.56468290 |
| 62 | CHUK | 0.54699415 |
| 63 | STK11 | 0.52725986 |
| 64 | ACVR1B | 0.52712655 |
| 65 | PRKAA2 | 0.49826174 |
| 66 | SIK1 | 0.46737893 |
| 67 | PDK1 | 0.46536038 |
| 68 | GRK7 | 0.45953164 |
| 69 | IGF1R | 0.43866701 |
| 70 | MAPKAPK5 | 0.43491733 |
| 71 | MELK | 0.40559327 |
| 72 | NME2 | 0.40538562 |
| 73 | MAP3K3 | 0.38988773 |
| 74 | PKN1 | 0.36574458 |
| 75 | MET | 0.36538313 |
| 76 | TAF1 | 0.35506989 |
| 77 | STK4 | 0.34525890 |
| 78 | RET | 0.33247885 |
| 79 | ABL1 | 0.32538300 |
| 80 | MAP3K5 | 0.30591803 |
| 81 | PAK3 | 0.28461680 |
| 82 | NLK | 0.28448521 |
| 83 | PIM1 | 0.24917722 |
| 84 | BRAF | 0.22867034 |
| 85 | FGFR1 | 0.21962562 |
| 86 | MAP3K1 | 0.20775051 |
| 87 | CDC42BPA | 0.20585560 |
| 88 | SMG1 | 0.19873762 |
| 89 | STK38L | 0.17597499 |
| 90 | EIF2AK2 | 0.16506590 |
| 91 | IRAK3 | 0.16078894 |
| 92 | GRK5 | 0.15879705 |
| 93 | EGFR | 0.14773015 |
| 94 | SGK2 | 0.14630268 |
| 95 | MAPK3 | 0.14185117 |
| 96 | MST4 | 0.13171202 |
| 97 | CDK4 | 0.12947142 |
| 98 | HIPK2 | 0.11295352 |
| 99 | MAPK7 | 0.09617423 |
| 100 | MAPK12 | 0.08435168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.58954723 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.35119706 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.05780395 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.95530820 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.88801394 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70853939 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68168652 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.62699144 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.37085513 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35961042 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.24357278 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.16841774 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08592809 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08374987 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.92642682 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85952807 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85178320 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.83514553 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.81041769 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79739781 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.77113606 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72184593 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69861784 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.69840110 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.57310852 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.56927538 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55895996 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51871947 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49870287 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47998900 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45989803 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44397739 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30747016 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.27213904 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.24379729 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23736583 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20195797 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16232657 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.15201512 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08294772 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06644174 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01306975 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.99894468 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.91756334 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.91009994 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85644560 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83582416 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82690206 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82649183 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81426995 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81253408 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80699457 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79641406 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76254261 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74823731 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73775300 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70790092 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69985913 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.65440905 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64348814 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62718719 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62441110 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.61780137 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59245154 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.58821718 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58460079 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.58364734 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56069442 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.54988046 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54891982 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54379992 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53143475 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.51958941 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51566720 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51511780 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49525752 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.46986738 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46342339 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43083641 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41156451 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41114247 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41057292 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38043059 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34710652 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34345401 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30396461 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28769905 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28523560 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.27491258 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25817308 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.25607562 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24962836 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24793041 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24577073 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24407314 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23800592 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23764884 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23543995 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20927463 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.20252098 |

